Biozek COVID-19 IgG/IgM Rapid Cassette Test Kits (BNCP-402 and and BNCP-402S) are a leading test kit producer in the Netherlands by Biozek.
Biozek’s rapid test kit produces a response within 10 minutes, giving a qualitative indication of infection or antibody presence. These kits should be used at the point-of-care by frontline healthcare providers.
Biozek’s external clinical studies have shown that the test kit’s obtained the following results;
The test kits include 30 test’s per box, 2 buffer solutions, instructions and 30 x 20uL pipettes
- a. IgG: Sensitivity: 99.9% / Specificity: 98% / Accuracy: 98.6%
- b. IgM: Sensitivity: 85% / Specificity: 96% / Accuracy: 92.9%
- c. CE marked for professional use and is therefore a registered IVD device
- d. Results Within 10 Minutes
- e. EC Approved
- f. Screen anywhere, anytime
- g. Identifies infection even in mild or asymptomatic cases
Biozek medical is a Netherlands based manufacturer with wide ranges of IVD products, as a biotechnology company that specializes in research & development, manufacturing and distribution of the medical diagnostics and innovative immunodiagnostic tools and point-of-care diagnostic test kits for the IVD community worldwide.
Features / Benefits
- Significant time and cost saving over lab methods
- Results within 10 minutes
- Identifies infection even in mild or asymptomatic cases
- Assists in the control of viral transmission
- Screen anywhere and everywhere
- Ideal as a triage and screening tool
- Accuracy of all tests available >95% (IgM) and >98% (IgG)
- Stock available for immediate dispatch 24/7